Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford has today announced the launch of a new centre of global research collaboration and excellence, the Pandemic Sciences Centre. The Pandemic Sciences Centre will harness the strong global research collaborations that the University of Oxford has developed over more than forty years. Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats.

University of Oxford

The Pandemic Sciences Centre, which will include a number of core institutes, will harness the strong global research collaborations that the University of Oxford has developed over more than forty years.  Its mission will be to ensure that the world is better equipped to create global, and equitable science-driven solutions to prepare for, identify, and counter future pandemic threats. The new centre will also build on the strong and unique collaborations developed in record time across national borders between academia, industry and public health bodies during the coronavirus pandemic.  

Louise Richardson, Vice-Chancellor of the University of Oxford, said:  

'The recent pandemic has demonstrated the unique contributions research universities like Oxford can make to pandemic preparedness. We are building on decades of medical research on infectious disease and data science, we have longstanding international partnerships and we have the ability to act and to adapt quickly. When aligned with industry and with public health bodies we can ensure that the world is never caught unprepared again.'

Within Oxford, the centre will draw together academics and experts from across its research and innovation community, including from infectious diseases, vaccinology, immunology, structural biology, diagnostics, drug discovery, clinical trials, data science, public health, and social and political sciences. Nationally and internationally, the Centre will foster a multisectoral approach and invest in agile platforms and partnerships. 

The centre will focus on three core themes:  

  • Accelerating understanding and insights: generating actionable knowledge and data (from pathogens through to patients) in near ‘real-time’ and making this globally accessible. 
  • Translating research into real-world solutions: creating and deploying effective, acceptable and equitable health technologies, including digital tools, diagnostics, treatments, and vaccines. 
  • Enhancing confidence, trust and impact:  identifying ways to strengthen societal and political engagement, resilience, and responsiveness. 

Professor Sir John Bell, Regius Professor of Medicine at Oxford University, said: 

'It would be easy to ignore just how much more serious a pandemic could have been this time around - other highly pathogenic viruses carry mortalities of 35-50% - imagine if we had a pandemic where one in three infected people died. 

'The University of Oxford is uniquely capable of leading a global step change in how we respond to the threat of emerging infections. By investing in sound science now, we can help to safeguard our resilience, global economic stability and health security for generations to come. We are ready to take our vision to build on these foundations to ensure society is better prepared and agile in its response to future threats.'

The inaugural Director of the centre will be Peter Horby, Professor of Emerging Infectious Diseases at the University of Oxford, who has worked on many global health threats including SARS-1, bird flu, Middle East Respiratory Syndrome, Ebola, Lassa fever, and plague. 

Professor Peter Horby, inaugural Director of the Pandemic Sciences Centre, said: 

'The COVID-19 pandemic has shown us that spectacular advances are possible through an alliance of science, the public sector and industry – creating digital disease control tools, diagnostic tests, and life-saving treatments and vaccines at unprecedented speed. But it should not take a pandemic to make this happen. This level of innovation and multi-sectoral collaboration must be applied, day in and day out, to prevent another catastrophe like COVID-19.'

Councillor Liz Leffman, the Leader of Oxfordshire County Council, said:

'Oxfordshire is a county of innovation with a world-class reputation and the presence of this new facility here in the county will enhance that further. It is a pleasure to see the county making such a contribution to work to improve the whole world’s resilience to pandemics. This centre will bring together experts across many disciplines to help counter the type of situation we have faced globally since early 2020. I wish this venture every success and eagerly anticipate news of its progress.'

The next few months will see significant activity to support the Centre’s development and engage our partners in this exciting initiative as the University looks to secure over £500 million to invest in this centre – with contributions from philanthropists, corporate partners and governments – to create an entity that will make a real difference to the world.

The University has collated its COVID-19 research under an easy-to-navigate hub.

Similar stories

NDM Researchers recognised in Queen’s Birthday Honours

The pioneering work of members of the University, including research into tackling the Coronavirus pandemic, has been recognised in The Queen's Birthday Honours List.

RECOVERY trial named David Sackett Trial of the Year 2020

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has been named David Sackett Trial of the Year by the Society for Clinical Trials (SCT). The award was presented today at the Society for Clinical Trials’ 42nd Annual Meeting.

Oxford University and Oracle partner to speed identification of COVID-19 variants

The partnership will enable global genomic sequencing and examination through a specialist platform developed on Oracle Cloud Infrastructure to help mitigate the impact of potentially dangerous COVID-19 variants.

Five new Academy of Medical Sciences Fellows from NDM

The Academy of Medical Sciences has elected 11 University of Oxford biomedical and health scientists to its fellowship five of which are from the Nuffield Department of Medicine. All were selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

Director of NDM's Jenner Institute elected to The Royal Society

Professor Adrian Hill, Director of the Jenner Institute becomes a Fellow for his leading role in the design and development of new vaccines for globally important infectious diseases over the course of over 25 years. He has demonstrated that non-replicating vectored vaccines, particularly simian adenoviruses used in heterologous prime-boost immunisation regimes, can protect safely through cellular as well as humoral immunity – supporting new vaccination approaches for malaria and Ebola.

National survey reveals big reductions in COVID-19 infections with single dose of Oxford-AZ and Pfizer vaccines

Data from the national COVID-19 Infection Survey, which is led by senior NIHR Oxford BRC researcher Professor Sarah Walker, has revealed the impact of vaccination on antibody responses and new infections in a large group of adults from the general population. This major community surveillance survey, one of the NIHR’s COVID-19 urgent public health studies, is a partnership between the University of Oxford, the Office of National Statistics (ONS) and the Department for Health and Social Care (DHSC).